Back

Clinical development concepts targeting mitochondria.

22 May 2016 (13:30 - 13:45)
Organised by:
Congress Presentation Part of: Targeting mitochondria to improve outcomes in heart failure Cell Signalling HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Professor Bertram Pitt

University of Michigan, Ann Arbor (United States of America)

3 More presentations in this session

Presentation thumbnail
Reaching the next level of drug development for heart failure: targetting mitochondria.
Professor S. Anker (Berlin, DE)
Presentation thumbnail
Elamipretide improves mitochondrial activity in the failing human heart.
Doctor B. Stauffer (Aurora, US)
Presentation thumbnail
Elamipretide in heart failure with reduced ejection fraction.
Professor H. Sabbah (Detroit, US)

Access the full session

Session thumbnail
Targeting mitochondria to improve outcomes in heart failure

The Event

Event poster

HEART FAILURE 2016

22 May 2016 13:30 CET
You may be interested in
thumbnail
Congress Presentation
GLP-1 receptor agonists are associated with higher mitochondrial coupling efficiency in the human heart
31 August 2025
thumbnail
Congress Session
New frontiers in heart failure therapies
19 May 2025
thumbnail
Congress Presentation
A phase 2a trial investigating ninerafaxstat - a novel cardiac mitotrope for the treatment of diabetic cardiomyopathy (IMPROVE-DiCE)
26 August 2022
thumbnail
Congress Presentation
RNA therapeutics for cardiovascular disease - discussion
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources